Miner K M, Manyak C L, Williams E, Jackson J, Jewell M, Gammon M T, Ehrenfreund C, Hayes E, Callahan L T, Zweerink H
Infect Immun. 1986 Apr;52(1):56-62. doi: 10.1128/iai.52.1.56-62.1986.
Twenty-eight independently derived monoclonal antibodies (MAb) directed against Escherichia coli J5 endotoxin were produced and characterized. Each MAb exhibited a specific titer by both radioimmunoassay and passive hemagglutination assay. Most of the MAb were of the immunoglobulin G isotype; however, several immunoglobulin M antibodies and one immunoglobulin A antibody were produced. When characterized for their capacity to cross-react with purified endotoxin preparations from several gram-negative bacteria, 22 MAb exhibited no cross-reactivity; 6 demonstrated a limited capacity to cross-react with other endotoxin preparations. When characterized for their capacity to react with the intact organism instead of the purified endotoxin the pattern of cross-reactivity was quite different. Most of the MAb were able to react with Salmonella minnesota Re595. Eighteen were able to react with E. coli O111:B4 (the parent strain of E. coli J5), 13 MAb reacted weakly with Pseudomonas aeruginosa, and 3 reacted weakly with Klebsiella pneumonia. The data imply that MAb generated against E. coli J5 endotoxin demonstrate greater cross-reactivity when assayed against the whole bacterium than when assayed against the corresponding purified endotoxin. We were unable to demonstrate that any of the 28 MAb could passively protect mice against lethal endotoxin challenge.
制备并鉴定了28种独立衍生的针对大肠杆菌J5内毒素的单克隆抗体(MAb)。每种MAb通过放射免疫测定和被动血凝试验均表现出特定的效价。大多数MAb为免疫球蛋白G同种型;然而,也产生了几种免疫球蛋白M抗体和一种免疫球蛋白A抗体。当对它们与几种革兰氏阴性菌的纯化内毒素制剂交叉反应的能力进行鉴定时,22种MAb无交叉反应;6种表现出与其他内毒素制剂有限的交叉反应能力。当对它们与完整生物体而非纯化内毒素反应的能力进行鉴定时,交叉反应模式大不相同。大多数MAb能够与明尼苏达沙门氏菌Re595反应。18种能够与大肠杆菌O111:B4(大肠杆菌J5的亲本菌株)反应,13种MAb与铜绿假单胞菌反应较弱,3种与肺炎克雷伯菌反应较弱。数据表明,针对大肠杆菌J5内毒素产生的MAb在针对全菌检测时比针对相应纯化内毒素检测时表现出更大的交叉反应性。我们未能证明这28种MAb中的任何一种能够被动保护小鼠免受致死性内毒素攻击。